Area of research
Psychiatry and Mental health · Behavioral Neuroscience
Research interest
Research interests include Stress Responses and Cortisol, Treatment of Major Depression, Tryptophan and brain disorders, and Schizophrenia research and treatment.
Acute and Chronic Macrophage Differentiation Modulates TREM2 in a Personalized Alzheimer’s Patient-Derived Assay
Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression
M1/M2 polarization in major depressive disorder: Disentangling state from trait effects in an individualized cell-culture-based approach
Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients
A simple approach to optimum pool size for pooled SARS-CoV-2 testing
Gray matter volume of rostral anterior cingulate cortex predicts rapid antidepressant response to ketamine
Clozapine modulates retinoid homeostasis in human brain and normalizes serum retinoic acid deficit in patients with schizophrenia
Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner
Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder
Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression
Inhibition of monoamine oxidase activity by repetitive transcranial magnetic stimulation: implications for inter-train interval and frequency
Combined treatment with memantine and galantamine‐CR compared with galantamine‐CR only in antidementia drug naïve patients with mild‐to‐moderate Alzheimer's disease
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
Cognitive-Behavioral Therapy as Continuation Treatment to Sustain Response After Electroconvulsive Therapy in Depression: A Randomized Controlled Trial
Predictors of Relapse in the Year After Hospital Discharge Among Patients With Schizophrenia
The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease
No consistent evidence for association between mtDNA variants and Alzheimer disease
Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale
Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder
Response trajectories in “real-world” naturalistically treated schizophrenia patients